NASDAQ: DFNST3 Defense Inc Stock
$6.57+2.31 (+54.23%)
Updated Jul 21, 2026
DFNS Price
$6.57
Fair Value Price
N/A
Market Cap
$3.17M
52 Week Low
$4.11
52 Week High
$1,948.75
P/E
-0.01x
P/B
0.09x
P/S
5.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.65M
Earnings
-$51.56M
Gross Margin
10.2%
Operating Margin
-1,330.65%
Profit Margin
-1,411.3%
Debt to Equity
2.72
Operating Cash Flow
-$10M
Beta
-0.27
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DFNS Overview
T3 Defense Inc. serves as a holding entity, concentrating its efforts on acquiring and overseeing enterprises within the defense industry. The firm provides a range of specialized services, including advanced artificial intelligence for defense purposes, comprehensive 3D mapping and surveillance systems, and unmanned aerial vehicles (UAVs). Founded in 2013, the company was initially known as Nukkleus Inc. before officially rebranding to T3 Defense Inc. in February 2026. Its corporate base is situated in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DFNS's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important DFNS news, forecast changes, insider trades & much more!
DFNS News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DFNS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DFNS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DFNS is good value based on its book value relative to its share price (0.09x), compared to the US Software - Application industry average (5.12x)
P/B vs Industry Valuation
DFNS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DFNS due diligence checks available for Premium users.
Valuation
DFNS fair value
Fair Value of DFNS stock based on Discounted Cash Flow (DCF)
Price
$6.57
Fair Value
$0.17
Overvalued by
3,830.95%
DFNS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DFNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
60.07x
Market
12.07x
DFNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.09x
Industry
5.12x
DFNS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DFNS's financial health
Profit margin
Revenue
$3.7M
Net Income
-$27.1M
Profit Margin
-743.1%
DFNS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DFNS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$315.5M
Liabilities
$98.4M
Debt to equity
2.72
DFNS's short-term liabilities ($91.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DFNS's short-term assets ($22.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DFNS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DFNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.9M
Investing
-$3.8M
Financing
$12.5M
DFNS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DFNS vs App Stocks
T3 Defense Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.